140 related articles for article (PubMed ID: 12187774)
1. [Appropriate administration schedule of D-penicillamine for pediatric Wilson's disease patients based on urinary copper excretion].
Fukuoka N; Morita S; Hamatani S; Okada H; Kondoh M; Imai T; Ohnishi S; Itoh S
Yakugaku Zasshi; 2002 Aug; 122(8):585-8. PubMed ID: 12187774
[TBL] [Abstract][Full Text] [Related]
2. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
[TBL] [Abstract][Full Text] [Related]
3. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Walshe JM
QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
[TBL] [Abstract][Full Text] [Related]
4. [Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
Atsuba Y; Nakahachi T; Terai T; Kozakai T
No To Shinkei; 1968 Feb; 20(2):187-95. PubMed ID: 5695072
[No Abstract] [Full Text] [Related]
5. Wilson's disease: assessment of D-penicillamine treatment.
Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
[TBL] [Abstract][Full Text] [Related]
6. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
Martins da Costa C; Baldwin D; Portmann B; Lolin Y; Mowat AP; Mieli-Vergani G
Hepatology; 1992 Apr; 15(4):609-15. PubMed ID: 1551638
[TBL] [Abstract][Full Text] [Related]
7. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
8. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.
Dzieżyc K; Litwin T; Chabik G; Członkowska A
Funct Neurol; 2015; 30(4):264-8. PubMed ID: 26727705
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
[TBL] [Abstract][Full Text] [Related]
10. Oral zinc sulphate for Wilson's disease.
Van Caillie-Bertrand M; Degenhart HJ; Visser HK; Sinaasappel M; Bouquet J
Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
[TBL] [Abstract][Full Text] [Related]
11. Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
LITIN RB; GOLDSTEIN NP; RANDALL RV; POWER MH; DIESSNER GR
Neurology; 1960 Feb; 10():123-6. PubMed ID: 14417516
[No Abstract] [Full Text] [Related]
12. The effect of certain chelating compounds on the urinary excretion of copper by the rat: observations on their clinical significance.
Gibbs K; Walshe JM
Clin Sci Mol Med; 1977 Oct; 53(4):317-20. PubMed ID: 913055
[TBL] [Abstract][Full Text] [Related]
13. Urinary copper excretion and hepatic copper concentrations in liver disease.
Frommer DJ
Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
[TBL] [Abstract][Full Text] [Related]
14. Urinary copper excretion after penicillamine in the diagnosis of Wilson's disease in children.
Gregorio GV; Mieli-Vergani G; Mowat AP
J Hepatol; 1993 Nov; 19(3):489. PubMed ID: 8151113
[No Abstract] [Full Text] [Related]
15. Penicillamine challenge test in the diagnosis of Wilson's disease.
Mazumder MW; Karim MB; Rukunuzzaman M
Mymensingh Med J; 2014 Jul; 23(3):489-95. PubMed ID: 25178601
[TBL] [Abstract][Full Text] [Related]
16. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
Gibbs K; Hanka R; Walshe JM
Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
[TBL] [Abstract][Full Text] [Related]
17. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Indaco A; Pellegrino L; Campanella G
Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
[No Abstract] [Full Text] [Related]
18. Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
Hefter H; Kuwert T; Herzog H; Arendt G; Stremmel W; Feinendegen LE
J Neurol; 1993 Nov; 241(1):49-53. PubMed ID: 8138822
[TBL] [Abstract][Full Text] [Related]
19. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
Marecek Z; Heyrovský A; Volek V
Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]